Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.3 - $1.31 $52,500 - $229,250
-175,000 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$0.61 - $1.84 $106,750 - $322,000
175,000 New
175,000 $242,000
Q1 2020

May 15, 2020

SELL
$3.83 - $8.79 $600,927 - $1.38 Million
-156,900 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$3.57 - $6.58 $67,473 - $124,362
18,900 Added 13.7%
156,900 $597,000
Q1 2019

May 15, 2019

BUY
$5.19 - $8.97 $275,070 - $475,410
53,000 Added 62.35%
138,000 $1.14 Million
Q3 2018

Nov 13, 2018

BUY
$9.54 - $13.87 $810,899 - $1.18 Million
85,000 New
85,000 $839,000

Others Institutions Holding KALA

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0

About Kala Pharmaceuticals, Inc.


  • Ticker KALA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,464,160
  • Market Cap $8.67M
  • Description
  • Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...
More about KALA
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.